The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on Helicobacter pylori Eradication

OBJECTIVE: We evaluated the safety and efficacy of vonoprazan-based amoxicillin and clarithromycin 7-day triple therapy (VAC) in comparison to proton pump inhibitor (PPI)-based (PAC) as a first-line treatment and vonoprazan-based amoxicillin and metronidazole 7-day triple therapy (VAM) in comparison...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Intern Med
Hlavní autoři: Sue, Soichiro, Kuwashima, Hirofumi, Iwata, Yuri, Oka, Hiroyuki, Arima, Isao, Fukuchi, Takehide, Sanga, Katsuyuki, Inokuchi, Yasuhiro, Ishii, Yuniba, Kanno, Masatomo, Terada, Masahiro, Amano, Hitoshi, Naito, Makoto, Iwase, Shigeru, Okazaki, Hiroshi, Komatsu, Kazuto, Kokawa, Atsushi, Kawana, Ichiro, Morimoto, Manabu, Saito, Toshifumi, Kunishi, Yosuke, Ikeda, Akihiko, Takahashi, Daisuke, Miwa, Haruo, Sasaki, Tomohiko, Tamura, Toshihide, Kondo, Masaaki, Shibata, Wataru, Maeda, Shin
Médium: Artigo
Jazyk:Inglês
Vydáno: The Japanese Society of Internal Medicine 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5498188/
https://ncbi.nlm.nih.gov/pubmed/28566587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.56.7833
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky